Joshua Boger

Josh Boger
Born (1951-04-12) April 12, 1951
EducationWesleyan University (BA)
Harvard University (MA, PhD)
SpouseAmy Schafer
AwardsBiotechnology Heritage Award
Othmer Gold Medal
External videos
video icon “Joshua Boger '73: Cure Entrepreneur”, Wesleyan University, Apr 6, 2011
video icon “The Innovator's Business, Managing in Balance”, Joshua Boger, February 25, 2014

Joshua S. Boger (born April 12, 1951) is an organic chemist and the founder of Vertex Pharmaceuticals Incorporated. He is considered a pioneer in the field of structure-based rational drug design. Drugs developed include amprenavir, an HIV protease inhibitor; telaprevir, a protease inhibitor for treatment of hepatitis C; and Kalydeco, for the treatment of cystic fibrosis. In 2003, Vertex was listed as one of forty worldwide Technology Pioneers by the World Economic Forum. As of 2012, Boger became executive chairman of Alkeus Pharmaceuticals.